| Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial EA Haavardsholm, AB Aga, IC Olsen, S Lillegraven, HB Hammer, T Uhlig, ... bmj 354, 2016 | 333 | 2016 |
| Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000–2010 AB Aga, E Lie, T Uhlig, IC Olsen, A Wierød, S Kalstad, E Rødevand, ... Annals of the rheumatic diseases 74 (2), 381-388, 2015 | 199 | 2015 |
| Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naïve patients classified according to … LB Nordberg, S Lillegraven, E Lie, AB Aga, IC Olsen, HB Hammer, T Uhlig, ... Annals of the rheumatic diseases 76 (2), 341-345, 2017 | 143 | 2017 |
| Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis MK Jonsson, NP Sundlisæter, HH Nordal, HB Hammer, AB Aga, IC Olsen, ... Annals of the rheumatic diseases 76 (12), 2031-2037, 2017 | 72 | 2017 |
| Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target … LB Nordberg, S Lillegraven, AB Aga, J Sexton, IC Olsen, E Lie, ... RMD open 4 (2), e000752, 2018 | 62 | 2018 |
| Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: associations to future good radiographic and physical outcomes NP Sundlisæter, AB Aga, IC Olsen, HB Hammer, T Uhlig, ... Annals of the Rheumatic Diseases 77 (10), 1421-1425, 2018 | 45 | 2018 |
| Effect of half-dose vs stable-dose conventional synthetic disease-modifying antirheumatic drugs on disease flares in patients with rheumatoid arthritis in remission: the ARCTIC … S Lillegraven, NP Sundlisæter, AB Aga, J Sexton, IC Olsen, H Fremstad, ... Jama 325 (17), 1755-1764, 2021 | 30 | 2021 |
| First step in the development of an ultrasound joint inflammation score for rheumatoid arthritis using a data-driven approach AB Aga, HB Hammer, IC Olsen, T Uhlig, TK Kvien, D van der Heijde, ... Annals of the rheumatic diseases 75 (8), 1444-1451, 2016 | 30 | 2016 |
| Predictors of sustained remission in patients with early rheumatoid arthritis treated according to an aggressive treat-to-target protocol N Paulshus Sundlisæter, IC Olsen, AB Aga, HB Hammer, T Uhlig, ... Rheumatology 57 (11), 2022-2031, 2018 | 28 | 2018 |
| Rheumatoid Arthritis Patients, Both Newly Diagnosed and Methotrexate Treated, Show More DNA Methylation Differences in CD4+ Memory Than in CD4+ Naïve T … K Guderud, LH Sunde, ST Flåm, MT Mæhlen, MD Mjaavatten, ... Frontiers in immunology 11, 194, 2020 | 27 | 2020 |
| The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapy MK Jonsson, AH Hensvold, M Hansson, AB Aga, J Sexton, ... Arthritis research & therapy 20, 1-11, 2018 | 23 | 2018 |
| The impact of ultrasound on the use and efficacy of intraarticular glucocorticoid injections in early rheumatoid arthritis: secondary analyses from a randomized trial examining … LB Nordberg, S Lillegraven, AB Aga, J Sexton, E Lie, HB Hammer, ... Arthritis & Rheumatology 70 (8), 1192-1199, 2018 | 22 | 2018 |
| Conventional versus ultrasound treat to target: no difference in magnetic resonance imaging inflammation or joint damage over 2 years in early rheumatoid arthritis U Sundin, AB Aga, Ø Skare, LB Nordberg, T Uhlig, HB Hammer, ... Rheumatology 59 (9), 2550-2555, 2020 | 21 | 2020 |
| Value of MRI and ultrasound for prediction of therapeutic response and erosive progression in patients with early rheumatoid arthritis managed by an aggressive treat-to-target … U Sundin, NP Sundlisater, AB Aga, J Sexton, LB Nordberg, HB Hammer, ... RMD open 7 (1), e001525, 2021 | 19 | 2021 |
| Peptidylarginine deiminase 4 (PAD4) activity in early rheumatoid arthritis MK Jonsson, T Kantyka, K Falkowski, A Aliko, AB Aga, S Lillegraven, ... Scandinavian Journal of Rheumatology 49 (2), 87-95, 2020 | 18 | 2020 |
| Development of a feasible and responsive ultrasound inflammation score for rheumatoid arthritis through a data-driven approach AB Aga, HB Hammer, IC Olsen, T Uhlig, TK Kvien, D van der Heijde, ... RMD open 2 (2), e000325, 2016 | 17 | 2016 |
| Fatigue in patients with early rheumatoid arthritis undergoing treat-to-target therapy: predictors and response to treatment K Holten, NP Sundlisater, S Lillegraven, J Sexton, LB Nordberg, E Moholt, ... Annals of the rheumatic diseases 81 (3), 344-350, 2022 | 16 | 2022 |
| MicroRNA expression differences in blood-derived CD19+ B cells of methotrexate treated rheumatoid arthritis patients F Heinicke, X Zhong, ST Flåm, J Breidenbach, M Leithaug, MT Maehlen, ... Frontiers in immunology 12, 663736, 2021 | 16 | 2021 |
| Development and reliability of a novel ultrasonographic joint-specific scoring system for synovitis with reference atlas for patients with juvenile idiopathic arthritis NK Sande, P Bøyesen, AB Aga, HB Hammer, B Flatø, J Roth, V Lilleby RMD open 7 (2), e001581, 2021 | 14 | 2021 |
| Achievement of remission in two early rheumatoid arthritis cohorts implementing different treat‐to‐target strategies V Norvang, GH Brinkmann, K Yoshida, S Lillegraven, AB Aga, J Sexton, ... Arthritis & Rheumatology 72 (7), 1072-1081, 2020 | 14 | 2020 |
Espen A. HaavardsholmProfessor (MD PhD)Verified email at medisin.uio.no
